住房状况的变化与美国退伍军人的癌症结果有关
Hannah C Decker1, Laura A Graham2, Ashley Titan3
1Hannah C. Decker (hannah.decker@ucsf.edu), University of California San Francisco, San Francisco, California.
Health affairs (Project Hope)
|February 5, 2024
概括
癌症诊断后的无家可归与肺癌和结直肠癌的退伍军人生存率较差有关. 获得住房改善了结果,但与连续住房的个人相比,失去住房使其恶化.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 癌症不成比例地影响着老年无家可归的成年人,这是一个脆弱的人群.
- 住房状况是健康的关键社会决定因素,影响癌症生存率.
- 了解住房不稳定对癌症结果的影响对于有针对性的干预措施至关重要.
研究的目的:
- 研究住房状况变化 (无家可归,获得/失去住房) 与退伍军人癌症诊断后的全因生存率之间的关联.
- 为了比较连续住房,连续无住房和经历癌症诊断后住房过渡的人的生存率.
主要方法:
- 在2011-2020年期间,对超过10万名被诊断患有肺癌,结直肠癌或乳腺癌的美国退伍军人进行了回顾性队列研究.
- 基于诊断时的住房状况和诊断后一年内住房变化的所有原因生存率的分析.
- 不同住房状况群体之间的生存曲线的比较.
主要成果:
- 5%的退伍军人在诊断时没有住房; 21%获得住房,1%在一年内失去住房.
- 持续无家可归的退伍军人和那些失去了住房的人在肺癌和结肠直肠癌诊断后的生存率较低.
- 获得住房的退伍军人与连续住房的退伍军人相比,没有观察到明显的生存差异.
结论:
- 癌症诊断后的无家可归和住房损失与退伍军人的生存率下降有关,特别是肺癌和结直肠癌.
- 旨在预防和解决癌症患者无家可归问题的政策对于改善健康结果至关重要.
- 确保稳定的住房是支持性癌症护理和生存的重要组成部分.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
270
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
相关概念视频
01:21Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:29Documentation in Long-Term and Home Healthcare Setting
892
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
892
02:20Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:20Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188